The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Abuse Treatment Market Research Report 2025
Synopsis
The global market for Drug Abuse Treatment was valued at US$ 20630 million in the year 2024 and is projected to reach a revised size of US$ 32070 million by 2031, growing at a CAGR of 6.6% during the forecast period.
Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
North America is the largest Drug Abuse Treatment market with about 48% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy"s Laboratories, Teva Pharmaceutical, PLIVA (Odyssey) etc. Top 5 companies occupied about 14% market share.
This report aims to provide a comprehensive presentation of the global market for Drug Abuse Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Abuse Treatment.
The Drug Abuse Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Abuse Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Abuse Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
PLIVA (Odyssey)
Segment by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Segment by Application
Hospital & Clinics
Residential (non-hospital)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Abuse Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Drug Abuse Treatment was valued at US$ 20630 million in the year 2024 and is projected to reach a revised size of US$ 32070 million by 2031, growing at a CAGR of 6.6% during the forecast period.
Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
North America is the largest Drug Abuse Treatment market with about 48% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy"s Laboratories, Teva Pharmaceutical, PLIVA (Odyssey) etc. Top 5 companies occupied about 14% market share.
This report aims to provide a comprehensive presentation of the global market for Drug Abuse Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Abuse Treatment.
The Drug Abuse Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Abuse Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Abuse Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
PLIVA (Odyssey)
Segment by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Segment by Application
Hospital & Clinics
Residential (non-hospital)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Abuse Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Abuse Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Opioid Addiction
1.2.3 Tobacco/Nicotine Addiction
1.2.4 Alcohol Dependence
1.3 Market by Application
1.3.1 Global Drug Abuse Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital & Clinics
1.3.3 Residential (non-hospital)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Abuse Treatment Market Perspective (2020-2031)
2.2 Global Drug Abuse Treatment Growth Trends by Region
2.2.1 Global Drug Abuse Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Abuse Treatment Historic Market Size by Region (2020-2025)
2.2.3 Drug Abuse Treatment Forecasted Market Size by Region (2026-2031)
2.3 Drug Abuse Treatment Market Dynamics
2.3.1 Drug Abuse Treatment Industry Trends
2.3.2 Drug Abuse Treatment Market Drivers
2.3.3 Drug Abuse Treatment Market Challenges
2.3.4 Drug Abuse Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Abuse Treatment Players by Revenue
3.1.1 Global Top Drug Abuse Treatment Players by Revenue (2020-2025)
3.1.2 Global Drug Abuse Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Drug Abuse Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Abuse Treatment Revenue
3.4 Global Drug Abuse Treatment Market Concentration Ratio
3.4.1 Global Drug Abuse Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Abuse Treatment Revenue in 2024
3.5 Global Key Players of Drug Abuse Treatment Head office and Area Served
3.6 Global Key Players of Drug Abuse Treatment, Product and Application
3.7 Global Key Players of Drug Abuse Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Abuse Treatment Breakdown Data by Type
4.1 Global Drug Abuse Treatment Historic Market Size by Type (2020-2025)
4.2 Global Drug Abuse Treatment Forecasted Market Size by Type (2026-2031)
5 Drug Abuse Treatment Breakdown Data by Application
5.1 Global Drug Abuse Treatment Historic Market Size by Application (2020-2025)
5.2 Global Drug Abuse Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Abuse Treatment Market Size (2020-2031)
6.2 North America Drug Abuse Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Abuse Treatment Market Size by Country (2020-2025)
6.4 North America Drug Abuse Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Abuse Treatment Market Size (2020-2031)
7.2 Europe Drug Abuse Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Abuse Treatment Market Size by Country (2020-2025)
7.4 Europe Drug Abuse Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Abuse Treatment Market Size (2020-2031)
8.2 Asia-Pacific Drug Abuse Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Abuse Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Abuse Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Abuse Treatment Market Size (2020-2031)
9.2 Latin America Drug Abuse Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Abuse Treatment Market Size by Country (2020-2025)
9.4 Latin America Drug Abuse Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Abuse Treatment Market Size (2020-2031)
10.2 Middle East & Africa Drug Abuse Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Abuse Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Abuse Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Indivior
11.1.1 Indivior Company Details
11.1.2 Indivior Business Overview
11.1.3 Indivior Drug Abuse Treatment Introduction
11.1.4 Indivior Revenue in Drug Abuse Treatment Business (2020-2025)
11.1.5 Indivior Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drug Abuse Treatment Introduction
11.2.4 Pfizer Revenue in Drug Abuse Treatment Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Alkermes
11.3.1 Alkermes Company Details
11.3.2 Alkermes Business Overview
11.3.3 Alkermes Drug Abuse Treatment Introduction
11.3.4 Alkermes Revenue in Drug Abuse Treatment Business (2020-2025)
11.3.5 Alkermes Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Drug Abuse Treatment Introduction
11.4.4 Novartis Revenue in Drug Abuse Treatment Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Drug Abuse Treatment Introduction
11.5.4 Mylan Revenue in Drug Abuse Treatment Business (2020-2025)
11.5.5 Mylan Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Drug Abuse Treatment Introduction
11.6.4 Cipla Revenue in Drug Abuse Treatment Business (2020-2025)
11.6.5 Cipla Recent Development
11.7 Glenmark
11.7.1 Glenmark Company Details
11.7.2 Glenmark Business Overview
11.7.3 Glenmark Drug Abuse Treatment Introduction
11.7.4 Glenmark Revenue in Drug Abuse Treatment Business (2020-2025)
11.7.5 Glenmark Recent Development
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Details
11.8.2 Dr. Reddy's Laboratories Business Overview
11.8.3 Dr. Reddy's Laboratories Drug Abuse Treatment Introduction
11.8.4 Dr. Reddy's Laboratories Revenue in Drug Abuse Treatment Business (2020-2025)
11.8.5 Dr. Reddy's Laboratories Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Drug Abuse Treatment Introduction
11.9.4 Teva Pharmaceutical Revenue in Drug Abuse Treatment Business (2020-2025)
11.9.5 Teva Pharmaceutical Recent Development
11.10 PLIVA (Odyssey)
11.10.1 PLIVA (Odyssey) Company Details
11.10.2 PLIVA (Odyssey) Business Overview
11.10.3 PLIVA (Odyssey) Drug Abuse Treatment Introduction
11.10.4 PLIVA (Odyssey) Revenue in Drug Abuse Treatment Business (2020-2025)
11.10.5 PLIVA (Odyssey) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Drug Abuse Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Opioid Addiction
Table 3. Key Players of Tobacco/Nicotine Addiction
Table 4. Key Players of Alcohol Dependence
Table 5. Global Drug Abuse Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drug Abuse Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Drug Abuse Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Drug Abuse Treatment Market Share by Region (2020-2025)
Table 9. Global Drug Abuse Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Drug Abuse Treatment Market Share by Region (2026-2031)
Table 11. Drug Abuse Treatment Market Trends
Table 12. Drug Abuse Treatment Market Drivers
Table 13. Drug Abuse Treatment Market Challenges
Table 14. Drug Abuse Treatment Market Restraints
Table 15. Global Drug Abuse Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Drug Abuse Treatment Market Share by Players (2020-2025)
Table 17. Global Top Drug Abuse Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Abuse Treatment as of 2024)
Table 18. Ranking of Global Top Drug Abuse Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Drug Abuse Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Drug Abuse Treatment, Headquarters and Area Served
Table 21. Global Key Players of Drug Abuse Treatment, Product and Application
Table 22. Global Key Players of Drug Abuse Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Drug Abuse Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Drug Abuse Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Drug Abuse Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Drug Abuse Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Drug Abuse Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Drug Abuse Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Drug Abuse Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Drug Abuse Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Drug Abuse Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Drug Abuse Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Drug Abuse Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Drug Abuse Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Drug Abuse Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Drug Abuse Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Drug Abuse Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Drug Abuse Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Drug Abuse Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Drug Abuse Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Drug Abuse Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Drug Abuse Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Drug Abuse Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Drug Abuse Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Drug Abuse Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Indivior Company Details
Table 48. Indivior Business Overview
Table 49. Indivior Drug Abuse Treatment Product
Table 50. Indivior Revenue in Drug Abuse Treatment Business (2020-2025) & (US$ Million)
Table 51. Indivior Recent Development
Table 52. Pfizer Company Details
Table 53. Pfizer Business Overview
Table 54. Pfizer Drug Abuse Treatment Product
Table 55. Pfizer Revenue in Drug Abuse Treatment Business (2020-2025) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Alkermes Company Details
Table 58. Alkermes Business Overview
Table 59. Alkermes Drug Abuse Treatment Product
Table 60. Alkermes Revenue in Drug Abuse Treatment Business (2020-2025) & (US$ Million)
Table 61. Alkermes Recent Development
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Drug Abuse Treatment Product
Table 65. Novartis Revenue in Drug Abuse Treatment Business (2020-2025) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Mylan Company Details
Table 68. Mylan Business Overview
Table 69. Mylan Drug Abuse Treatment Product
Table 70. Mylan Revenue in Drug Abuse Treatment Business (2020-2025) & (US$ Million)
Table 71. Mylan Recent Development
Table 72. Cipla Company Details
Table 73. Cipla Business Overview
Table 74. Cipla Drug Abuse Treatment Product
Table 75. Cipla Revenue in Drug Abuse Treatment Business (2020-2025) & (US$ Million)
Table 76. Cipla Recent Development
Table 77. Glenmark Company Details
Table 78. Glenmark Business Overview
Table 79. Glenmark Drug Abuse Treatment Product
Table 80. Glenmark Revenue in Drug Abuse Treatment Business (2020-2025) & (US$ Million)
Table 81. Glenmark Recent Development
Table 82. Dr. Reddy's Laboratories Company Details
Table 83. Dr. Reddy's Laboratories Business Overview
Table 84. Dr. Reddy's Laboratories Drug Abuse Treatment Product
Table 85. Dr. Reddy's Laboratories Revenue in Drug Abuse Treatment Business (2020-2025) & (US$ Million)
Table 86. Dr. Reddy's Laboratories Recent Development
Table 87. Teva Pharmaceutical Company Details
Table 88. Teva Pharmaceutical Business Overview
Table 89. Teva Pharmaceutical Drug Abuse Treatment Product
Table 90. Teva Pharmaceutical Revenue in Drug Abuse Treatment Business (2020-2025) & (US$ Million)
Table 91. Teva Pharmaceutical Recent Development
Table 92. PLIVA (Odyssey) Company Details
Table 93. PLIVA (Odyssey) Business Overview
Table 94. PLIVA (Odyssey) Drug Abuse Treatment Product
Table 95. PLIVA (Odyssey) Revenue in Drug Abuse Treatment Business (2020-2025) & (US$ Million)
Table 96. PLIVA (Odyssey) Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Drug Abuse Treatment Picture
Figure 2. Global Drug Abuse Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Abuse Treatment Market Share by Type: 2024 VS 2031
Figure 4. Opioid Addiction Features
Figure 5. Tobacco/Nicotine Addiction Features
Figure 6. Alcohol Dependence Features
Figure 7. Global Drug Abuse Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Drug Abuse Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospital & Clinics Case Studies
Figure 10. Residential (non-hospital) Case Studies
Figure 11. Drug Abuse Treatment Report Years Considered
Figure 12. Global Drug Abuse Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Drug Abuse Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Drug Abuse Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Drug Abuse Treatment Market Share by Players in 2024
Figure 16. Global Top Drug Abuse Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Abuse Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Drug Abuse Treatment Revenue in 2024
Figure 18. North America Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Drug Abuse Treatment Market Share by Country (2020-2031)
Figure 20. United States Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Drug Abuse Treatment Market Share by Country (2020-2031)
Figure 24. Germany Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Drug Abuse Treatment Market Share by Region (2020-2031)
Figure 32. China Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Drug Abuse Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Drug Abuse Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Drug Abuse Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Indivior Revenue Growth Rate in Drug Abuse Treatment Business (2020-2025)
Figure 48. Pfizer Revenue Growth Rate in Drug Abuse Treatment Business (2020-2025)
Figure 49. Alkermes Revenue Growth Rate in Drug Abuse Treatment Business (2020-2025)
Figure 50. Novartis Revenue Growth Rate in Drug Abuse Treatment Business (2020-2025)
Figure 51. Mylan Revenue Growth Rate in Drug Abuse Treatment Business (2020-2025)
Figure 52. Cipla Revenue Growth Rate in Drug Abuse Treatment Business (2020-2025)
Figure 53. Glenmark Revenue Growth Rate in Drug Abuse Treatment Business (2020-2025)
Figure 54. Dr. Reddy's Laboratories Revenue Growth Rate in Drug Abuse Treatment Business (2020-2025)
Figure 55. Teva Pharmaceutical Revenue Growth Rate in Drug Abuse Treatment Business (2020-2025)
Figure 56. PLIVA (Odyssey) Revenue Growth Rate in Drug Abuse Treatment Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
